Polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) therapy in diffuse large B-cell lymphoma in patients aged 80 years or older: a real-world study.

Saved in:
Bibliographic Details
Title: Polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) therapy in diffuse large B-cell lymphoma in patients aged 80 years or older: a real-world study.
Authors: Yamada T; Department of Hematology, Gifu Prefectural General Medical Center, Gifu, Japan., Nakamura N; Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan. nakamura.nobuhiko.s1@f.gifu-u.ac.jp., Goto H; Department of Hematology, Chuno Kosei Hospital, Gifu, Japan., Hara T; Department of Hematology and Oncology, Matsunami General Hospital, Gifu, Japan., Kasahara S; Department of Hematology, Gifu Municipal Hospital, Gifu, Japan., Fukuno K; Department of Hematology, Japanese Red Cross Takayama Hospital, Gifu, Japan., Sawada M; Department of Hematology, Japanese Red Cross Gifu Hospital, Gifu, Japan., Nakamura H; Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan., Hayase N; Department of Hematology, Gifu Prefectural General Medical Center, Gifu, Japan., Goto T; Department of Hematology, Gifu Municipal Hospital, Gifu, Japan., Suzaki T; Department of Hematology, Gifu Municipal Hospital, Gifu, Japan., Fujita K; Department of Hematology and Oncology, Matsunami General Hospital, Gifu, Japan., Lee S; Department of Hematology and Oncology, Matsunami General Hospital, Gifu, Japan., Kanemura N; Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan., Shimizu M; Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan., Tsurumi H; Department of Hematology and Oncology, Matsunami General Hospital, Gifu, Japan.
Source: Annals of hematology [Ann Hematol] 2025 Oct; Vol. 104 (10), pp. 5191-5200. Date of Electronic Publication: 2025 Oct 10.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1432-0584
DOI:10.1007/s00277-025-06619-0